PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 12:08 AM ET

Sponsor Check › Person

Steve Gorlin

Related person on Form D filings · address states as listed: FL, GA, CA, CO, NJ, UT, MN, NV, TX · listed May 1, 2009 → Sep 21, 2016

15issuers
49Form D filings
2009–2016years listed

Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 23, 2026, 11:57 PM ET · SEC enforcement last checked: not yet

Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.

Key records

The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.

1. Lawsuits

None found in sources searched.

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:57 PM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.

Not yet searched.

Search queued. Results are added automatically; check back later or follow this page to be notified.

3. Bankruptcies

None found in sources searched.

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:57 PM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons are made for sponsors and sponsor groups, not individual people.

5. Money to insiders and sales commissions

12 of 40 offerings report sales commissions totalling $8,480,764; 3 report finder's fees totalling $282,000; 6 report proceeds to related persons totalling $3,073,833. (includes amounts the issuer reported as estimates)

SourceOffering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell it
EDGAR ↗Feb 26, 2026 D
File 021-574816
$540,000 (est.)$0$0Stonehaven, LLC BrokerCheck CRD 118913 ↗
via Terrance Joseph Philips (CRD 8015702 ↗)

Stonehaven, LLC BrokerCheck CRD 118913 ↗
via Marc Christopher Rucinski (CRD 4543011 ↗)
EDGAR ↗May 22, 2025 D
File 021-546928
$4,130,000 (est.)$0$0M M Dillon & Co. LLC BrokerCheck CRD 19878 ↗
via Elena Ulansky (CRD 7654267 ↗)

M M Dillion & Co. LLC BrokerCheck CRD 19878 ↗
via Jeff Robert Swarz (CRD 1563420 ↗)
EDGAR ↗Feb 28, 2025 D
File 021-539551
$1,400,000 (est.)$0$0M M Dillon & Co. LLC BrokerCheck CRD 19878 ↗
via Elena Ulansky (CRD 7654267 ↗)

M M Dillion & Co. LLC BrokerCheck CRD 19878 ↗
via Jeff Robert Swarz (CRD 1563420 ↗)
EDGAR ↗Feb 28, 2025 D
File 021-539577
$700,000 (est.)$0$0M M Dillon & Co. LLC BrokerCheck CRD 19878 ↗
via Elena Ulansky (CRD 7654267 ↗)

M M Dillion & Co. LLC BrokerCheck CRD 19878 ↗
via Jeff Robert Swarz (CRD 1563420 ↗)
EDGAR ↗Mar 8, 2024 D
File 021-507023
$84,000$0$1,013,833
Director fees and executive compensation payments (includes amounts paid to a former director)
M M Dillon & Co. LLC BrokerCheck CRD 19878 ↗
via Elena Ulansky (CRD 7654267 ↗)

M M Dillion & Co. LLC BrokerCheck CRD 19878 ↗
via Jeff Robert Swarz (CRD 1563420 ↗)
EDGAR ↗Feb 22, 2024 D
File 021-505805
$0$0$0None listed on this filing
EDGAR ↗Jul 25, 2022 D
File 021-453512
$0$0$0None listed on this filing
EDGAR ↗Nov 3, 2020 D
File 021-379530
$0$0$0None listed on this filing
EDGAR ↗Apr 8, 2019 D
File 021-336656
$0$0$0None listed on this filing
EDGAR ↗Jan 18, 2019 D/A
File 021-330270
$68,000$0$0LaidLaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗
EDGAR ↗Jan 18, 2019 D
File 021-330875
$156,000 (est.)$0$0Finsoft Consultants, Inc. no CRD number reported
Virginia Dadey no CRD number reported
Ashley Johnson no CRD number reported
EDGAR ↗Feb 16, 2018 D
File 021-305893
$600,000$0$0Titan Securities BrokerCheck CRD 131392 ↗
EDGAR ↗Jan 8, 2018 D
File 021-302620
$0$0$0None listed on this filing
EDGAR ↗Sep 26, 2017 D
File 021-295429
$0$0$0None listed on this filing
EDGAR ↗Jun 29, 2017 D
File 021-289735
$0$0$0None listed on this filing
EDGAR ↗Apr 10, 2017 D
File 021-284457
$0$0$0None listed on this filing
EDGAR ↗Jan 5, 2017 D
File 021-277748
$0$0$0None listed on this filing
EDGAR ↗Sep 23, 2016 D
File 021-271170
$0$0$0None listed on this filing
EDGAR ↗Sep 22, 2016 D
File 021-271131
$0$0$0None listed on this filing
EDGAR ↗Sep 21, 2016 D
File 021-271060
$0$0$0None listed on this filing
EDGAR ↗May 16, 2016 D
File 021-263277
$0$0$0None listed on this filing
EDGAR ↗May 3, 2016 D
File 021-262510
$167,764$0$0Laidlaw and Company (UK) Ltd. BrokerCheck CRD 119037 ↗
EDGAR ↗Jan 8, 2016 D
File 021-254824
$0$40,000 (est.)$800,000 (est.)
This amount represents 1 year of salaries to executives.
None listed on this filing
EDGAR ↗Jan 5, 2016 D
File 021-254485
$0$0$0None listed on this filing
EDGAR ↗Dec 7, 2015 D/A
File 021-252410
$0$0$0None listed on this filing
EDGAR ↗Dec 7, 2015 D/A
File 021-252411
$0$0$0None listed on this filing
EDGAR ↗Dec 7, 2015 D/A
File 021-252413
$0$0$0None listed on this filing
EDGAR ↗Oct 15, 2015 D
File 021-249410
$0$0$0None listed on this filing
EDGAR ↗Aug 5, 2015 D
File 021-245114
$0$0$0None listed on this filing
EDGAR ↗Jul 17, 2015 D/A
File 021-242356
$0$0$0None listed on this filing
EDGAR ↗May 8, 2015 D
File 021-239478
$0$0$0None listed on this filing
EDGAR ↗Apr 30, 2015 D
File 021-238927
$185,000$0$560,000
Repayment of outstanding indebtedness to a person named in Item 3.
Chardan Capital Markets LLC BrokerCheck CRD 120128 ↗
EDGAR ↗Apr 7, 2015 D
File 021-237425
$0$0$0None listed on this filing
EDGAR ↗Dec 31, 2014 D
File 021-231172
$50,000 (est.)$0$0Chardan Capital Markets LLC BrokerCheck CRD 120128 ↗
EDGAR ↗Mar 1, 2013 D/A
File 021-183624
$400,000 (est.)$0$100,000 (est.)
Reimbursement for offering expenses
GILFORD SECURITIES INCORPORATED BrokerCheck CRD 8076 ↗
EDGAR ↗Nov 29, 2010 D
File 021-151121
$0$0$0None listed on this filing
EDGAR ↗Jun 21, 2010 D
File 021-143781
$0$0$100,000 (est.)
Reimbursement for offering expenses
None listed on this filing
EDGAR ↗May 3, 2010 D
File 021-141447
$0$0$0None listed on this filing
EDGAR ↗Nov 19, 2009 D
File 021-114396
$0 (est.)$42,000 (est.)$0Lyons Capital, LLC no CRD number reported
EDGAR ↗Aug 21, 2009 D
File 021-133856
$0$200,000$500,000 (est.)Jason Lyons no CRD number reported

As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Appears on these filings

SourceIssuerRoleFiledFormOfferingSoldInvestorsMin. investment
EDGAR ↗CoRegen, Inc.Executive Officer, Director
President and Vice Chairman of the Board
Feb 26, 2026D$13,500,000
similar: $2,000,000–$19,999,994
$13,500,0001
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗CoRegen, Inc.Executive Officer, Director
President of the Issuer
May 22, 2025D$62,640,000
similar: $2,000,000–$19,999,994
$62,640,0008
similar: 2–16
$25,000
similar: $10,000–$50,000
EDGAR ↗CoRegen, Inc.DirectorFeb 28, 2025D$10,000,002
similar: $2,000,000–$19,999,994
$10,000,0021
similar: 2–16
$25,000
similar: $10,000–$50,000
EDGAR ↗CoRegen, Inc.DirectorFeb 28, 2025D$20,750,000
similar: $2,000,000–$19,999,994
$20,750,0007
similar: 2–16
$25,000
similar: $10,000–$50,000
EDGAR ↗CoRegen, Inc.Executive Officer, Director
Chief Executive Officer of the Issuer
Mar 8, 2024D$12,870,000
similar: $2,000,000–$19,999,994
$12,870,00031
similar: 2–16
$25,000
similar: $10,000–$50,000
EDGAR ↗CoRegen, Inc.Executive Officer, Director
Chief Executive Officer of the Issuer
Feb 22, 2024DIndefinite
similar: $2,000,000–$19,999,994
$14,500,0001
similar: 2–16
$14,500,000
similar: $10,000–$50,000
EDGAR ↗BIOVIE INC.DirectorJul 25, 2022D$6,000,000
similar: $2,000,000–$19,999,994
$6,000,0001
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Rion LLCDirector
Vice Chairman
Nov 3, 2020D$20,250,000
similar: $2,000,000–$19,999,994
$00
similar: 2–16
$1,000,000
similar: $10,000–$50,000
EDGAR ↗SmartPharm Therapeutics, Inc.DirectorApr 8, 2019D$10,527,003
similar: $829,831–$9,999,998
$10,527,00327
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗AperiSys, Inc.Executive Officer, DirectorJan 18, 2019D/A$1,000,000
similar: $829,831–$9,999,998
$680,0008
similar: 2–15
$25,000
similar: $10,000–$54,310
EDGAR ↗Vavotar Life Sciences LLCExecutive Officer, DirectorJan 18, 2019D$10,000,000
similar: $829,831–$9,999,998
$10,000,00031
similar: 2–15
$6,250
similar: $10,000–$54,310
EDGAR ↗AperiSys, Inc.Executive Officer, DirectorJan 14, 2019D/A$1,000,000
similar: $829,831–$9,999,998
$680,0008
similar: 2–15
$25,000
similar: $10,000–$54,310
EDGAR ↗AperiSys, Inc.Executive Officer, DirectorJan 11, 2019D$1,000,000
similar: $829,831–$9,999,998
$680,0008
similar: 2–15
$25,000
similar: $10,000–$54,310
EDGAR ↗Vicapsys Life Sciences, Inc.Executive Officer, DirectorFeb 16, 2018D$6,000,000
similar: $2,000,000–$19,999,994
$50,0003
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Vicapsys Life Sciences, Inc.Executive Officer, DirectorJan 8, 2018DIndefinite
similar: $2,000,000–$19,999,994
$052
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗POLARITYTE, INC.DirectorSep 26, 2017D$17,750,002
similar: $2,000,000–$19,999,994
$17,750,00210
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Rion LLCDirector
Governor and Vice Chairman
Jun 29, 2017D$9,280,000
similar: $2,000,000–$19,999,994
$5,160,00322
similar: 2–16
$50,000
similar: $10,000–$50,000
EDGAR ↗POLARITYTE, INC.DirectorApr 10, 2017D$1
similar: $500,000–$7,000,000
$11
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Ontrak, Inc.DirectorJan 5, 2017D$5,562,796
similar: $829,831–$9,999,998
$5,562,7964
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Vavotar Life Sciences LLCExecutive Officer, DirectorSep 23, 2016D$80,833,200
similar: $829,831–$9,999,998
$80,833,2001
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Vavotar Life Sciences LLCExecutive Officer, DirectorSep 22, 2016D$21,000,000
similar: $829,831–$9,999,998
$21,000,0003
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Vavotar Life Sciences LLCExecutive Officer, DirectorSep 21, 2016D$40,605,000
similar: $829,831–$9,999,998
$40,605,0001
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Vavotar Life Sciences LLCExecutive Officer, DirectorMay 16, 2016D$4,500,000
similar: $829,831–$9,999,998
$3,515,00011
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗H-CYTE, INC.Director
Co-Chairman
May 3, 2016D$2,000,000
similar: $829,831–$9,999,998
$1,398,03332
similar: 2–15
$100,000
similar: $10,000–$54,310
EDGAR ↗Genomic Cancer Institute, Inc.DirectorJan 8, 2016D$1,499,999
similar: $829,831–$9,999,998
$00
similar: 2–15
$1
similar: $10,000–$54,310
EDGAR ↗Vavotar Life Sciences LLCExecutive Officer, DirectorJan 5, 2016D$675
similar: $829,831–$9,999,998
$6758
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗AperiSys, Inc.Executive Officer, DirectorDec 7, 2015D/A$20,700,000
similar: $829,831–$9,999,998
$3,470,0005
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗AperiSys, Inc.Executive Officer, DirectorDec 7, 2015D/A$2,000,000
similar: $829,831–$9,999,998
$2,000,0001
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗AperiSys, Inc.Executive Officer, DirectorDec 7, 2015D/A$7,400
similar: $829,831–$9,999,998
$6,75020
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗AperiSys, Inc.Executive Officer, DirectorDec 4, 2015D$20,700,000
similar: $829,831–$9,999,998
$3,470,0005
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗AperiSys, Inc.Executive Officer, DirectorDec 4, 2015D$2,000,000
similar: $829,831–$9,999,998
$2,000,0001
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗AperiSys, Inc.Executive Officer, DirectorDec 4, 2015D$7,400
similar: $829,831–$9,999,998
$6,75020
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Ontrak, Inc.DirectorOct 15, 2015D$3,553,030
similar: $829,831–$9,999,998
$3,553,0301
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗ImmunityBio, Inc.DirectorAug 5, 2015D$17,000,000
similar: $2,000,000–$19,999,994
$17,000,0001
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗ImmunityBio, Inc.DirectorJul 17, 2015D/A$78,004,041
similar: $2,000,000–$19,999,994
$78,004,04111
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗ImmunityBio, Inc.DirectorJun 24, 2015D$71,004,041
similar: $2,000,000–$19,999,994
$71,004,0419
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗DemeRx, Inc.DirectorMay 8, 2015D$499,998
similar: $1,694,259–$16,000,000
$289,5699
similar: 1–13
$1,000
similar: $10,000–$55,000
EDGAR ↗Ontrak, Inc.DirectorApr 30, 2015D$2,121,212
similar: $1,500,000–$10,000,000
$2,121,2124
similar: 1–11
No minimum reported
similar: $25,000–$100,000
EDGAR ↗H-CYTE, INC.DirectorApr 7, 2015DIndefinite
similar: $829,831–$9,999,998
$092
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Ontrak, Inc.DirectorDec 31, 2014D$1,100,000
similar: $829,831–$9,999,998
$1,100,0008
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗DemeRx, Inc.Executive Officer, DirectorMar 1, 2013D/A$11,000,000
similar: $1,694,259–$16,000,000
$5,137,02835
similar: 1–13
$5
similar: $10,000–$55,000
EDGAR ↗DemeRx, Inc.Executive Officer, DirectorFeb 27, 2013D/A$11,000,000
similar: $1,694,259–$16,000,000
$5,137,02835
similar: 1–13
$5
similar: $10,000–$55,000
EDGAR ↗DemeRx, Inc.Executive Officer, DirectorSep 4, 2012D$8,250,000
similar: $1,694,259–$16,000,000
$00
similar: 1–13
$5
similar: $10,000–$55,000
EDGAR ↗MIMEDX GROUP, INC.DirectorNov 29, 2010D$5,000,000
similar: $2,000,000–$19,999,994
$2,080,00020
similar: 2–16
$5,000
similar: $10,000–$50,000
EDGAR ↗DemeRx, Inc.Executive Officer, DirectorJun 21, 2010D$15,000,000
similar: $2,000,000–$19,999,994
$00
similar: 2–16
$2
similar: $10,000–$50,000
EDGAR ↗DemeRx, Inc.Executive Officer, DirectorMay 3, 2010DIndefinite
similar: $2,000,000–$19,999,994
$855
similar: 2–16
$5
similar: $10,000–$50,000
EDGAR ↗MIMEDX GROUP, INC.DirectorNov 19, 2009D$5,000,000
similar: $2,000,000–$19,999,994
$675,0006
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Celnyx, Inc.Executive Officer, DirectorAug 21, 2009D$4,500,000
similar: $2,000,000–$19,999,994
$3,000,00024
similar: 2–16
$100,000
similar: $10,000–$50,000
EDGAR ↗MIMEDX GROUP, INC.DirectorMay 1, 2009D$4,025,000
similar: $2,000,000–$19,999,994
$1,420,00013
similar: 2–16
No minimum reported
similar: $10,000–$50,000

Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.

"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years (5 industry/exemption sets on this page); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other listings under the same name

Not linked to this profile — a second identifier (same issuer, same sponsor group) was not found. Could be the same person or a different one.

  • Steve Gorlin — address state NC, 1 issuer, Jan 31, 2012 → Jan 31, 2012

Connections as of Oct 23, 2026, 5:45 PM ET

Listed alongside — 40 names on the same filings (0 management entities, 40 people)

People and management entities the issuers listed as related persons on the same Form D filings as Steve Gorlin. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.

  • Charles Farrahar — 21 shared filings (5 issuers) · roles as listed: Executive Officer, Director
  • John Thomas — 13 shared filings (5 issuers) · roles as listed: Executive Officer, Director · also listed on 10 other issuers
  • Charles E. Koob — 9 shared filings (2 issuers) · roles as listed: Director, Executive Officer · also listed on 1 other issuer
  • Parker H. Petit — 7 shared filings (3 issuers) · roles as listed: Director, Executive Officer · also listed on 2 other issuers
  • Bruce Hack — 6 shared filings (2 issuers) · role as listed: Director
  • Edward J. Benz, Jr. — 6 shared filings (1 issuer) · role as listed: Director
  • Jeffrey L. Raney — 5 shared filings (1 issuer) · role as listed: Executive Officer · also listed on 1 other issuer
  • Terren Peizer — 5 shared filings (2 issuers) · roles as listed: Executive Officer, Director · also listed on 1 other issuer
  • Martin A. Bell — 5 shared filings (1 issuer) · role as listed: Executive Officer · also listed on 1 other issuer
  • Bert W. O'Malley — 5 shared filings (1 issuer) · role as listed: Director
  • Clifford C. Dasco, M.D. — 5 shared filings (1 issuer) · roles as listed: Director, Executive Officer
  • David Lonard, PhD — 5 shared filings (1 issuer) · role as listed: Executive Officer
  • Larry Papasan — 5 shared filings (2 issuers) · role as listed: Director
  • David Smith — 4 shared filings (1 issuer) · role as listed: Director · also listed on 13 other issuers
  • Richard A. Anderson — 4 shared filings (1 issuer) · roles as listed: Executive Officer, Director · also listed on 1 other issuer
  • Susan Etzel — 4 shared filings (1 issuer) · role as listed: Executive Officer
  • Henry Mellon — 4 shared filings (1 issuer) · role as listed: Director
  • Holger Weis — 4 shared filings (1 issuer) · role as listed: Executive Officer
  • Jesse W. Crowne — 4 shared filings (1 issuer) · role as listed: Executive Officer · also listed on 1 other issuer
  • William Haseltine, PhD. — 4 shared filings (1 issuer) · role as listed: Director
  • Jonathan W. Simons — 4 shared filings (1 issuer) · role as listed: Director
  • Richard Berman — 4 shared filings (1 issuer) · role as listed: Director · also listed on 4 other issuers
  • Patrick Soon-Shiong — 3 shared filings (1 issuer) · role as listed: Director · also listed on 19 other issuers
  • Kurt M Eichler — 3 shared filings (1 issuer) · role as listed: Director
  • Deborah C. Mash, Ph.D. — 3 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Steven M. Paul, M.D. — 3 shared filings (1 issuer) · role as listed: Director
  • Andrew K. Rooke — 3 shared filings (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • Henry Ji, Ph.D. — 3 shared filings (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • Lawrence Friedhoff, M.D., Ph.D., FACP — 3 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • E. Douglas Kramer — 3 shared filings (1 issuer) · role as listed: Executive Officer
  • Robert Rosen — 3 shared filings (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • Richard Kusserow — 3 shared filings (1 issuer) · role as listed: Director
  • Richard Gomberg — 3 shared filings (1 issuer) · role as listed: Executive Officer
  • Barry J. Simon, M.D. — 3 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Patrick Soon-Shiong, M.D. — 3 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • John T. Potts, Jr., M.D. — 3 shared filings (1 issuer) · role as listed: Director
  • Marvin Igelman — 3 shared filings (1 issuer) · role as listed: Director
  • Jon Mogford — 3 shared filings (2 issuers) · roles as listed: Director, Executive Officer · also listed on 1 other issuer
  • Lee Fleisher, M.D. — 3 shared filings (1 issuer) · role as listed: Director
  • Matthew Miller — 3 shared filings (2 issuers) · roles as listed: Executive Officer, Director · also listed on 6 other issuers

Other offering types (Regulation A and Regulation Crowdfunding)

None found in sources searched.

Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.

Export this report as PDF (members · included free during the launch period)

Change history

No corrections have been requested for this page.

Facts from public records only, each linked to its source. No ratings, no opinions. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Steve Gorlin appears on a new Form D, or when a court case or SEC action is matched to them. See plans →